Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-04 @ 6:44 AM
Study NCT ID:
NCT01495351
Status:
COMPLETED
Last Update Posted:
2017-09-25
First Post:
2011-11-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
Sponsor:
AHS Cancer Control Alberta
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MM11-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None